CEO: Stanley T. Crooke

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.


Key numbers

Market Capitalization:8244258430
Shares Outstanding: 140663000
Float: 127964366.349
Next Earning Date:2020-02-26
TTm EPS: 3.1353
TTm Dividend Rate:
200 days moving average:66.27
50 days moving average: 58.92
One day percent Change: 1.42



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,